title: Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults.
abstract: This study was designed as a parallel-groups comparison of trivalent preparations of split-virus vaccine (SVV) and whole-virus influenza vaccine (WVV) in healthy young and elderly adults. Interleukin-2 (IL-2) was measured in the supernatants of peripheral blood mononuclear cell (PBMC) cultures stimulated with live virus preparations of the two strains of influenza A contained in the vaccine. The duration of increased in vitro IL-2 production after vaccination was significantly different between the two strains of virus. A/Beijing/353/89 resulted in an IL-2 response that was quite short (< 7 weeks) while the response to A/Texas/16/89 was much more prolonged (> 12 weeks). In the first 12 weeks after vaccination, there was no difference in IL-2 levels between SVV and WVV recipients in either the young or elderly groups. The duration of the response to A/Texas/16/89 was slightly longer in WVV recipients as measured at 26 weeks postvaccination. The viral strain contained in the vaccine appears to be an important variable in determining the duration of the IL-2 response to vaccination.
authors.affiliation: Department of Medicine, University of Alberta, Edmonton, Canada.
authors.forename: J E
authors.initials: JE
authors.lastname: McElhaney
authors.forename: G S
authors.initials: GS
authors.lastname: Meneilly
authors.forename: M J
authors.initials: MJ
authors.lastname: Pinkoski
authors.forename: K E
authors.initials: KE
authors.lastname: Lechelt
authors.forename: R C
authors.initials: RC
authors.lastname: Bleackley
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000276:immunology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000276:immunology*; D007376:Interleukin-2 / Q000096:biosynthesis*; D008297:Male; D008875:Middle Aged
chemical_list: D007252:Influenza Vaccines; D007376:Interleukin-2